280 related articles for article (PubMed ID: 8541533)
21. Recombinant human erythropoietin for the correction of cancer associated anemia with and without concomitant cytotoxic chemotherapy.
Ludwig H; Sundal E; Pecherstorfer M; Leitgeb C; Bauernhofer T; Beinhauer A; Samonigg H; Kappeler AW; Fritz E
Cancer; 1995 Dec; 76(11):2319-29. PubMed ID: 8635038
[TBL] [Abstract][Full Text] [Related]
22. Prediction of response to recombinant human erythropoietin (rHuEpo) in anemia of malignancy.
Cazzola M; Ponchio L; Pedrotti C; Farina G; Cerani P; Lucotti C; Novella A; Rovati A; Bergamaschi G; Beguin Y
Haematologica; 1996; 81(5):434-41. PubMed ID: 8952157
[TBL] [Abstract][Full Text] [Related]
23. Once weekly versus twice weekly subcutaneous administration of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis.
Lui SF; Law CB; Ting SM; Li P; Lai KN
Clin Nephrol; 1991 Nov; 36(5):246-51. PubMed ID: 1752075
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics and pharmacodynamics of subcutaneous and intraperitoneal administration of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis.
Lui SF; Chung WW; Leung CB; Chan K; Lai KN
Clin Nephrol; 1990 Jan; 33(1):47-51. PubMed ID: 2302870
[TBL] [Abstract][Full Text] [Related]
25. Once weekly recombinant human erythropoietin treatment for cancer-induced anemia in children with acute lymphoblastic leukemia receiving maintenance chemotherapy: a randomized case-controlled study.
Abdelrazik N; Fouda M
Hematology; 2007 Dec; 12(6):533-41. PubMed ID: 17852440
[TBL] [Abstract][Full Text] [Related]
26. [The use of erythropoietin beta, two to three times per week, once per week and once every other week: meta-analysis of two clinical trials].
Pljesa S
Med Pregl; 2007; 60(3-4):123-7. PubMed ID: 17853722
[TBL] [Abstract][Full Text] [Related]
27. Early prediction of response to recombinant human erythropoietin in patients with the anemia of renal failure by serum transferrin receptor and fibrinogen.
Beguin Y; Loo M; R'Zik S; Sautois B; Lejeune F; Rorive G; Fillet G
Blood; 1993 Oct; 82(7):2010-6. PubMed ID: 8400253
[TBL] [Abstract][Full Text] [Related]
28. [Inadequate erythropoietin production (epo) in patients with multiple myeloma].
Kostova G; Siljanovski N
Prilozi; 2004; 25(1-2):53-66. PubMed ID: 15735535
[TBL] [Abstract][Full Text] [Related]
29. Optimization of recombinant human erythropoietin therapy after allogeneic hematopoietic stem cell transplantation.
Baron F; Sautois B; Baudoux E; Matus G; Fillet G; Beguin Y
Exp Hematol; 2002 Jun; 30(6):546-54. PubMed ID: 12063021
[TBL] [Abstract][Full Text] [Related]
30. An extended maintenance dosing regimen of epoetin alfa 80,000 U every 3 weeks in anemic patients with cancer receiving chemotherapy.
Montoya VP; Xie J; Williams D; Woodman RC; Wilhelm FE
Support Care Cancer; 2007 Dec; 15(12):1385-92. PubMed ID: 17541653
[TBL] [Abstract][Full Text] [Related]
31. Beneficial influence of recombinant human erythropoietin therapy on the rate of progression of chronic renal failure in predialysis patients.
Jungers P; Choukroun G; Oualim Z; Robino C; Nguyen AT; Man NK
Nephrol Dial Transplant; 2001 Feb; 16(2):307-12. PubMed ID: 11158405
[TBL] [Abstract][Full Text] [Related]
32. Erythropoietin treatment under polychemotherapy in patients with gynecologic malignancies: a prospective, randomized, double-blind placebo-controlled multicenter study.
Kurz Ch; Marth Ch; Windbichler G; Lahousen M; Medl M; Vavra N; Sevelda P
Gynecol Oncol; 1997 Jun; 65(3):461-6. PubMed ID: 9190976
[TBL] [Abstract][Full Text] [Related]
33. Follow-up of very low birth weight infants after erythropoietin treatment to prevent anemia of prematurity.
Soubasi V; Kremenopoulos G; Diamanti E; Tsantali C; Sarafidis K; Tsakiris D
J Pediatr; 1995 Aug; 127(2):291-7. PubMed ID: 7636658
[TBL] [Abstract][Full Text] [Related]
34. Erythropoietin plus granulocyte colony-stimulating factor in the treatment of myelodysplastic syndromes. Identification of a subgroup of responders. The Spanish Erythropathology Group.
Remacha AF; Arrizabalaga B; Villegas A; Manteiga R; Calvo T; Julià A; Fernández Fuertes I; González FA; Font L; Juncà J; del Arco A; Malcorra JJ; Equiza EP; de Mendiguren BP; Romero M
Haematologica; 1999 Dec; 84(12):1058-64. PubMed ID: 10586205
[TBL] [Abstract][Full Text] [Related]
35. [Treatment of multiple myeloma associated anemia with human recombinant erythropoietin in a hemodialysis patient].
Muszytowski M; Nowak J; Wojnicz M; Zalewska A; Ruszkiewicz-Fołda M
Pol Arch Med Wewn; 1995 Jan; 93(1):77-9. PubMed ID: 7479222
[TBL] [Abstract][Full Text] [Related]
36. [Comparative study of the efficacy of different regimens of intermittent subcutaneous dosing of erythropoietin beta in treatment of renal anemia in chronic dialysis patients].
Nesić V; Ostrić V; Kovacević Z; Dimković N; Curić S; Lazarević M; Ratković M; Bogdanović J; Jelacić R
Med Pregl; 2005; 58(5-6):279-85. PubMed ID: 16526235
[TBL] [Abstract][Full Text] [Related]
37. Prediction of response to erythropoietin treatment in chronic anemia of cancer.
Ludwig H; Fritz E; Leitgeb C; Pecherstorfer M; Samonigg H; Schuster J
Blood; 1994 Aug; 84(4):1056-63. PubMed ID: 7741835
[TBL] [Abstract][Full Text] [Related]
38. [A double-blind dose ranging study of weekly subcutaneous administration of rHuEPO (KRN5702) on post-phlebotomy anemia of patients scheduled for predeposit autologous blood transfusion (multicenter late PhII study)].
Tsutsui H; Sugioka Y; Takaku F; Yamamura H; Asano S; Minami S; Wakimoto N; Takahashi K; Ikeda Y; Tachibana S
Nihon Seikeigeka Gakkai Zasshi; 1993 Oct; 67(10):919-34. PubMed ID: 8263364
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of recombinant human erythropoietin in critically ill patients: a randomized controlled trial.
Corwin HL; Gettinger A; Pearl RG; Fink MP; Levy MM; Shapiro MJ; Corwin MJ; Colton T;
JAMA; 2002 Dec; 288(22):2827-35. PubMed ID: 12472324
[TBL] [Abstract][Full Text] [Related]
40. Recombinant human erythropoietin treatment of anemia in renal transplant patients.
Lezaic V; Djukanovic L; Pavlovic-Kentera V
Ren Fail; 1995 Nov; 17(6):705-14. PubMed ID: 8771243
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
